BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1721425)

  • 1. Indefinite small bowel allograft survival after limited immunosuppressive therapy is not due to specific hyporesponsiveness.
    Langrehr JM; Hoffman RA; Müller AR; Lee KK; Demetris AJ; Schraut WH
    Transplant Proc; 1991 Dec; 23(6):3248-50. PubMed ID: 1721425
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of FK 506 on the survival of rat small bowel allografts.
    Takeda Y; Okajima K; Iga C; Date K; Ryo T; Niki M; Asaka K; Tezuka K; Isozaki H
    Transplant Proc; 1991 Dec; 23(6):3251. PubMed ID: 1721426
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytoimmunologic monitoring of small bowel allograft recipients.
    Graeb C; Stangl MJ; Mebert H; Fischer T; Hammer C
    Transplant Proc; 1992 Jun; 24(3):1153-4. PubMed ID: 1376515
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-VLA-4 and cyclosporine synergistically prolong rat heterotopic small bowel allografts.
    Tice DG; Bruch D; Ikramuddin S
    Transplant Proc; 1996 Oct; 28(5):2496. PubMed ID: 8907920
    [No Abstract]   [Full Text] [Related]  

  • 5. Failure of donor irradiation to prolong allograft survival in small bowel transplantation in rats.
    Lee TK; Langrehr JM; Moynihan HL; Stangl MJ; Lee KK; Schraut WH
    Transplant Proc; 1992 Jun; 24(3):1183-4. PubMed ID: 1604579
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of short-term immunosuppressive therapy with FK 506 or CyA on the donor in small intestine allotransplantation in rats.
    Santiago SF; Fukuzawa M; Azuma T; Okada A
    Transplant Proc; 1992 Jun; 24(3):1189. PubMed ID: 1376520
    [No Abstract]   [Full Text] [Related]  

  • 7. Fulminant graft-versus-host disease after FK 506 treatment in fully allogeneic small bowel transplantation.
    de Bruin RW; HogenEsch H; Heineman E; Jeekel J; Marquet RL
    Transplant Proc; 1991 Dec; 23(6):3257-9. PubMed ID: 1721429
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of donor pretreatment with FK 506 upon small intestine allotransplantation in rats.
    Santiago SF; Fukuzawa M; Azuma T; Okada A
    Transplant Proc; 1991 Dec; 23(6):3243-5. PubMed ID: 1721423
    [No Abstract]   [Full Text] [Related]  

  • 9. Reversal of experimental small bowel transplantation rejection with cyclosporine A.
    Liu Q; Yang R; Grosfeld JL; Collins MH; Pescovitz MD
    Transplant Proc; 1996 Oct; 28(5):2508-9. PubMed ID: 8907925
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of spleen transplantation and cyclosporine A treatment to ameliorate survival after small bowel transplantation.
    Pirenne J; D'Silva M; Jacquet N
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1206. PubMed ID: 8442087
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of donor-specific transfusion and FK 506 on small intestine allotransplantation.
    Fukuzawa M; Santiago S; Nakata S; Shirakura R; Okada A
    Transplant Proc; 1991 Dec; 23(6):3252-4. PubMed ID: 1721427
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of FK 506 on orthotopic small bowel transplantation in rats.
    Utsunomiya H; Tanaka K; Uemoto S; Kato H; Nishizawa T; Yamamoto E; Ozawa K
    Transplant Proc; 1992 Jun; 24(3):1191. PubMed ID: 1376521
    [No Abstract]   [Full Text] [Related]  

  • 13. Intraportal donor-specific transfusion given 24 hours before small bowel transplantation with cyclosporine and FK 506.
    Takara T; Tchervenkov JI; Guttman FM; Fecteau A; Rosenmann E
    Transplant Proc; 1994 Jun; 26(3):1622. PubMed ID: 7518150
    [No Abstract]   [Full Text] [Related]  

  • 14. Small bowel transplantation in the rat: the effect of donor-specific transfusion 24 hours pretransplant and cyclosporine.
    Fecteau A; Tchervenkov J; Guttman FM; Rosenmann E
    Transplant Proc; 1992 Jun; 24(3):1166. PubMed ID: 1604571
    [No Abstract]   [Full Text] [Related]  

  • 15. CD8+ host cells infiltrate the intestinal mucosa after allogeneic small bowel transplantation even in the absence of acute rejection.
    Nüssler NC; Cicalese L; Hoffman RA; Rastellini C; Neuhaus P; Simmons RL; Schraut WH
    Transplant Proc; 1996 Oct; 28(5):2456. PubMed ID: 8907898
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction of tolerance to small bowel allotransplants by mixed allogeneic chimerism.
    Orloff MS; Orloff SL; DeMara EM; Coppage ML; Leong N; Fallon MA
    Transplant Proc; 1994 Jun; 26(3):1585-6. PubMed ID: 8030048
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence that indefinite survival of small bowel allografts achieved by a brief course of cyclosporine or FK506 is not due to systemic hyporesponsiveness.
    Langrehr JM; Hoffman RA; Demetris AJ; Lee KK; Neuhaus P; Wren SM; Ildstad ST; Schraut WH
    Transplantation; 1992 Sep; 54(3):505-10. PubMed ID: 1384185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of FK 506 on graft survival in rat small intestinal allografts.
    Date K; Okajima K; Takeda Y; Isozaki H; Tezuka K; Ryo T
    Transplant Proc; 1992 Jun; 24(3):1173. PubMed ID: 1376516
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of immunosuppression and syngeneic and allogeneic small bowel transplantation on the fat-stimulated release of cholecystokinin and neurotensin in rats.
    Schlemminger R; Gieseler RK; Schleef J; Nustede R; Köhler H; Schafmayer A
    Transplant Proc; 1994 Jun; 26(3):1673-4. PubMed ID: 8030083
    [No Abstract]   [Full Text] [Related]  

  • 20. The interaction of gamma irradiation of the allograft and recipient administration of cyclosporine in rat small bowel transplantation.
    Foster PF; Sankary HN; Kociss K; Xiao F; Williams JW
    Transplant Proc; 1992 Jun; 24(3):1175-6. PubMed ID: 1604576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.